Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
61.37B
Market cap61.37B
Price-Earnings ratio
17.11
Price-Earnings ratio17.11
Dividend yield
—
Dividend yield—
Average volume
16.80M
Average volume16.80M
High today
$42.51
High today$42.51
Low today
$41.82
Low today$41.82
Open price
$42.30
Open price$42.30
Volume
6.95M
Volume6.95M
52 Week high
$105.65
52 Week high$105.65
52 Week low
$41.82
52 Week low$41.82

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $42.35. The company's market cap stands at 61.37B, with a P/E ratio of 17.11.

On 2026-10-07, Boston Scientific(BSX) stock moved within a range of $41.82 to $42.51. With shares now at $42.35, the stock is trading +1.3% above its intraday low and -0.4% below the session's peak.

Trading activity shows a volume of 6.95M, compared to an average daily volume of 16.8M.

The stock's 52-week range extends from a low of $41.82 to a high of $105.65.

The stock's 52-week range extends from a low of $41.82 to a high of $105.65.

BSX News

TipRanks 6h
Boston Scientific Announces New COO and Operating Structure

Boston Scientific ( (BSX) ) has issued an update. Boston Scientific announced on Oct. 7, 2026, that longtime cardiovascular executive Joseph M. Fitzgerald will...

TipRanks 7h
Boston Scientific appoints Joseph Fitzgerald COO

Boston Scientific (BSX) announced the appointment of Joseph Fitzgerald to executive vice president and COO, effective Jan. 1, 2027. In this role, Fitzgerald wil...

Simply Wall St 9h
Boston Scientific Issues Class I Recall For Imager II Angiographic Catheters

Boston Scientific (NYSE:BSX) has started a voluntary global Class I recall of its Imager II Angiographic Catheters due to tip fracture risk. The recall follows...

Boston Scientific Issues Class I Recall For Imager II Angiographic Catheters

Analyst ratings

79%

of 34 ratings
Buy
79.4%
Hold
20.6%
Sell
0%

More BSX News

TipRanks 19h
Boston Scientific Stock Stumbles as Wall Street Turns Wary - TipRanks

...

Boston Scientific Stock Stumbles as Wall Street Turns Wary - TipRanks
TipRanks 21h
Boston Scientific initiated with an Underweight at Barclays

Barclays initiated coverage of Boston Scientific (BSX) with an Underweight rating and $165 price target The firm rolled out coverage of the medical suppliers an...

TipRanks 2d
Citi cuts Boston Scientific target, opens ‘downside 90-day catalyst watch’

Citi lowered the firm’s price target on Boston Scientific (BSX) to $48 from $50 and keeps a Neutral rating on the shares. Citi also opened a “downside 90-day ca...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.